Search
Menu
Home
HTB
2015
January
HTB
January 2015
Contents
Editorial
January/February 2015: Volume 16 Number 1/2
Conference reports
Five Nations Conference on HIV and Hepatitis – 8-9 December 2014, London
Summary of the pre-conference clinical course
Hepatitis C drug access: Europe is the new Africa
45th Union World Conference on Lung Health, 28 October – 1 November 2014, Barcelona, Spain
Good outcomes within the National Bedaquiline Clinical Access programme in South Africa
Pharmacokinetics and safety of moxifloxacin in children
TB in the ARROW trial of children on ART
Problems giving current second line TB drugs to children
Antiretrovirals
Dolutegravir and Truimeq approved in England
London prescribing guidelines updated to include dolutegravir and Triumeq
Adequate cerebrospinal fluid exposure of efavirenz when dosed at 400 mg
Treatment access
Morocco’s acceptance of EU patent law threatens millions of lives
Global Fund releases end-2104 numbers
India rejects Gilead’s patent application for sofosbuvir
Pregnancy
Three drug regimen superior for preventing vertical transmission in the PROMISE study
Side effects
CMV associated with 50% increased risk of non-AIDS related mortality in HIV positive people
Impact of smoking on life expectancy in HIV infection
Hepatitis coinfection
Hepatitis C combination from AbbVie licensed in the UK: ombitasvir/paritaprevir/ritonavir (Viekirax) and dasabuvir (Exviera)
HIV prevention and transmission
HIV prevention budget for 2015 slashed by 50%, then rapidly reinstated
Grassroots demand grows for early access to PrEP in the UK
New York announces new policy to dramatically reduce HIV incidence by 2020
Basic science and immunology
Is HIV weakening over time? Unlikely, and a sense of déjà vu…
Quantification of latent HIV induction by vorinostat
On the web
Online video resource – Aidspans video on gay life and death in Ghana
Online article – Journal of Virus Eradication: New open-access journal
Community report – RITA: HIV and kidney disease
PDFs
January/February 2015: Volume 16 Number 1/2
HTB RSS
Early access
Lenacapavir submitted to the US FDA with an indication for HIV PrEP
20 December 2024
i-Base guides updated online
5 December 2024
All early access reports
Current issues
December 2024
November 2024
October 2024
Back issues
Special report
Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan
9 November 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate